Catalyst
Slingshot members are tracking this event:
Mast Therapeutics Completes Enrollment of of Phase 3 EPIC Study for Treatment of Sickle Cell
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MSTX |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 22, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Complete Enrollment, Epic Trial, Sickle Cell Disease
